2025-05-12
Avadel Management
Other
/yr
employee
contract
Chesterfield
Missouri
63005
United States
Title: Director, Peer to Peer Marketing & Key Opinion Leader Engagement
Position Type: Full Time
Location: Remote, Remote, US
Requsition ID: 1272
Description:
About Avadel Pharmaceuticals plc
Who We Are: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, other approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. LUMRYZ TM (sodium oxybate) extended release for oral suspension, applies our proprietary drug delivery technology to allow for a single, once-at-bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night’s sleep. An extended-release medication sounds like a simple innovation, but it is what has been lacking for more than 20 years, and we believe this can be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.
What We Do: FDA-approved LUMRYZ (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. The FDA found LUMRYZ to be clinically superior to currently marketed twice nightly oxybate products and granted LUMRYZ seven years of Orphan Drug Exclusivity for adults on May 1, 2023, and again for pediatric patients 7 years and older on October 16, 2024. In both instances, FDA found that LUMRYZ makes a major contribution to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal awakening to take a second dose.
How We Work: At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage – our “secret sauce”. The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility, being courageous, taking insights to impact, and togetherness. In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.
We are seeking team members who have a passion for making a meaningful impact on the lives of patients. We need individuals who will dive in, roll up their sleeves, and join us in our mission to continue the launch of LUMRYZ for the narcolepsy community and be part of building and shaping an exciting future together.
Position Summary:
The Director, Peer to Peer (P2P) Marketing & Key Opinion Leader (KOL) Engagement will be a critical member of the brand team responsible for continuing the launch of LUMRYZ for the treatment of narcolepsy. We are looking for a passionate P2P marketer who is equally comfortable developing high-level brand strategies and “rolling up their sleeves” to implement tactics. S/he will lead the development and implementation of P2P & KOL engagement activities as the medical marketer within the brand team. This is a unique opportunity for a dynamic, experienced pharmaceutical marketer to be a major contributor to an exciting launch in the orphan/rare disease area to help people living with the chronic CNS condition of narcolepsy.
Essential Functions:
HCP Peer-to-Peer & KOL Marketing Expertise (physician, NP/PA, etc.)
Agency & Budget Management
Other Key Duties/Responsibilities:
Other Competencies and Behaviors:
Experience and Qualifications:
Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
PI270752316